Hanyue Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hanyue Qiu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chongzhou Zhang
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Innovative Drug Research Center, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
1 shared publication- Cui Liu
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Innovative Drug Research Center, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 400044, P. R. China
1 shared publication Hongjing Cheng
Department of Pathology, Union Hospital of Jilin University, Changchun, P. R. China
1 shared publicationHongya Yan
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Innovative Drug Research Center, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
1 shared publication- Jian Jiao
College of Geoexploration Science and Technology, Jilin University, Changchun, China
1 shared publication Jing Li
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Innovative Drug Research Center, School of Pharmaceutical Sciences, Chongqing University, Chongqing, P. R. China
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Mg/Mn bi-single-atom carbon dot nanozymes with enhanced SOD-like activity and fluorescence for hepatoprotection
- 21 April 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessMg/Mn bi-single-atom carbon dot nanozymes with enhanced SOD-like activity and fluorescence for hepatoprotection
- Open Access
- 13 June 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (28) , 10963-10968
Catalytic asymmetric intramolecular propargylation of cyclopropanols to access the cuparane core
The catalytic asymmetric propargylation of cyclopropanols has been developed using a new PyBox ligand, yielding cyclopentanones with an all-carbon quaternary stereogenic center and an adjacent quaternary gem-dimethyl carbon center.
- 13 June 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (28) , 10963-10968
Open AccessCatalytic asymmetric intramolecular propargylation of cyclopropanols to access the cuparane core
The catalytic asymmetric propargylation of cyclopropanols has been developed using a new PyBox ligand, yielding cyclopentanones with an all-carbon quaternary stereogenic center and an adjacent quaternary gem-dimethyl carbon center.
- 2 November 2022
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 32 (11) , 1145-1159
An updated patent review of IDO1 inhibitors for cancer (2018–2022)
Indoleamine 2,3-dioxygenase 1 (IDO1) is highly related to the immune evasion of a wide range of malignancies due to its role in the immune suppression caused by the depletion of tryptophan (Trp) an...
- 2 November 2022
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 32 (11) , 1145-1159
An updated patent review of IDO1 inhibitors for cancer (2018–2022)
Indoleamine 2,3-dioxygenase 1 (IDO1) is highly related to the immune evasion of a wide range of malignancies due to its role in the immune suppression caused by the depletion of tryptophan (Trp) an...